Interview with Dr Constantine Lyketsos,14 May 2013

Abstract

Get full access to this article

View all access options for this article.

References

Lyketsos

C. G.

Colenda

C. C.

Beck

Blank

Doraiswamy

M. P.

Kalunian

D. A.

Task Force of American Association for Geriatric Psychiatry (2006) Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. The American Journal of Geriatric Psychiatry 14: 561–572. doi:10.1097/01.JGP.0000221334.65330.5.

Porsteinsson

A. P.

Drye

L. T.

Pollock

B. G.

Devanand

D. P.

Frangakis

Ismail

CitAD Research Group (2014) Effect of citalopram on agitation in Alzheimer disease: The CitAD randomized clinical trial. JAMA 311: 682–691. doi:10.1001/jama.2014.9.

Rosenberg

P. B.

Johnston

Lyketsos

C. G.

(2006) A clinical approach to mild cognitive impairment. American Journal of Psychiatry 163: 1884–1890.

Rosenberg

P. B.

Mielke

M. M.

Appleby

Leoutsakos

J. M.

Lyketsos

C. G.

(2011) Neuropsychiatric symptoms in MCI subtypes: The importance of executive dysfunction. International Journal of Geriatric Psychiatry 26: 364–372. doi:10.1002/gps.253.

Tighe

S. K.

Oishi

Mori

Smith

G. S.

Albert

Lyketsos

C. G.

Mielke

M. M.

(2012) Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer’s dementia. The Journal of Neuropsychiatry and Clinical Neurosciences 24: 484–488. doi:10.1176/appi.neuropsych.1112037.

Trzepacz

P. T.

Cummings

Konechnik

Forrester

T. D.

Chang

Dennehy

E. B.

Lyketsos

(2013) Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer’s disease. International Psychogeriatrics 25: 707–719. doi:10.1017/S104161021200214.